Shahbazi Hamed reported NAGE

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001942711-26-000001

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 24, 2026

Published

Jun 26, 2026

Ingested by INSIDER

Nov 5, 03:50 UTC

Last re-read

Nov 5, 03:50 UTC

Extracted facts

Filer

Shahbazi Hamed

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Niagen Bioscience, Inc. — Stock Option (right to buy)

Ticker

NAGE

Shares

31.7K

Price per share

$0

Execution date (reported)

Jun 24, 2026

Owned after transaction

31.7K shares

Days from execution to publication

2

What this establishes

Shahbazi Hamed filed this Form 4 reporting a grant or award of NAGE on Jun 24, 2026. It became public on Jun 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Shahbazi Hamedcik:0001942711

Issuer

Niagen Bioscience, Inc.cik:0001386570

Revision history · 0

No field has changed since this record was first ingested.